Hence, we tested whether the combined intracellular detection of CD137, TNF, and IFNγ was feasible, and whether the addition of CD107a to the panel enhanced the detection of tumor-specific reactive TILs in vitro. This evidence concerns the gene IFNG and neoplasm.